Shots: Biogen and Apple collaborated to evaluate the role of Apple Watch and iPhone in monitoring cognitive performance and screening for the decline in cognitive health including mild cognitive impairment (MCI) The study will initiate in late 2021 and will enroll participants including young and aging adults with a range of cognitive performance The study […]Read More
Shots: Google has launched the Google Health Studies app for Android phones with the initial focus on respiratory diseases such as COVID-19. The app is now available in the play store Google allied with researchers from Harvard Medical School and Boston Children Hospital for the first study, which will be open to adults in the […]Read More
Shots: Elsevier acquires Shadow Health to enhance its extensive portfolio and clinical practice offerings for HCPs during a time of continued growth in telehealth Elsevier works with healthcare educators to prepare students, nursing and HCPs and provide innovative learning tools and analytics that improve educational outcomes and help prepare students for healthcare practice The acquisition […]Read More
Shots: RetinAI signs a multi-year collaboration with Novartis under which RetinAI’s IT solutions and AI tools will be employed to support multiple projects in ophthalmology and digital health The first project under the agreement will support a multi-center international clinical study involving patients with nAMD. The study is designed to investigate the influence of OCT […]Read More
Shots: Exactech has acquired intelligent patient wearables and digital communication solutions maker Muvr Labs to expand its Active Intelligence platform of smart technologies portfolio The Muvr platform includes patient wearables, mobile device applications, and chatbot texting, allowing the surgeons to remotely monitor patient recovery Exactech expects a pilot launch of the Muvr technology in early […]Read More
Shots: Kaia Health signs an exclusive agreement with Chiesi Group to commercialize the Kaia Health COPD Pulmonary Rehabilitation app in the EU The app is CE marked in EU as a Class 1 medical device and has been investigated in one pilot trial and is the subject of an ongoing randomized control trial in the […]Read More
Shots: The funding focuses on fostering the development of a digital health ecosystem in the fields of cardiometabolic and renal diseases, oncology, and women’s health Bayer G4A partnership program offers 2 digital health collaboration segments. Under its Growth Track, selected early-stage startups to receive $0.1M funding to accelerate market uptake and tailored business acceleration clinics, […]Read More
Shots: Pear Therapeutics launches Somryst as the first PDT intended for use in the treatment of patients with chronic insomnia aged > 22yrs. It addresses the issues of chronic insomnia by delivering (CBTi) approach that trains the brain and body to sleep In a study of ~1,400 adults with CI, PDT reduced the amount of […]Read More
Shots: Health2Sync reported the results of their clinical study in Taiwan, demonstrating that integrating Fitbit wearable devices with their Health2Sync patient management platform can help users to control T2DM Results: reduction in HbA1C (0.33%); patients who did mod. to high-intensity activity duration of at least 150mins/ week, reduction in HbA1C (0.66%); reduction in fasting BG […]Read More
Shots: The US FDA has permitted marketing of a device intended for the temporary reduction of sleep disturbance related to nightmares in patients aged ≥22 yrs. suffering from nightmare disorder or PTSD Nightware utilizes Apple Watch and an iPhone that is configured and logged into a software application and the Nightware server and monitors the […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
